Roundtable discussion: tadalafil study group.
Kloner
Robert A
RA
Division of Cardiovascular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. rkloner@goodsam.org
Brindis
Ralph G
RG
Cheitlin
Melvin D
MD
Kuritzky
Louis
L
Miller
Thomas A
TA
Padma-Nathan
Harin
H
Rosen
Raymond C
RC
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D002243:Carbolines / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D004347:Drug Interactions; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D020030:Nitric Oxide Donors / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D000068581:Tadalafil
D002243:Carbolines; D020030:Nitric Oxide Donors; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil; D015106:3',5'-Cyclic-GMP Phosphodiesterases